These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 12522456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
    Shinohara A, Asai T, Izutsu K, Ota Y, Takeuchi K, Hangaishi A, Kanda Y, Chiba S, Motokura T, Kurokawa M.
    Leuk Lymphoma; 2007 Feb; 48(2):418-20. PubMed ID: 17325908
    [No Abstract] [Full Text] [Related]

  • 3. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N, Adachi A, Mori T, Kamata H, Nakahara J, Yokoyama K, Yamada T, Kizaki M, Sakamoto M, Ikeda Y, Okamoto S.
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA, Broxson EH, Dole MG, Filippa DA, George D, Lyden D, Dunkel IJ.
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP, Viswanatha DS, Habermann TM, Patnaik MM.
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [Abstract] [Full Text] [Related]

  • 7. [Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma].
    Tajika K, Tamai H, Mizuki T, Nakayama K, Yamaguchi H, Dan K.
    Rinsho Ketsueki; 2010 Feb; 51(2):138-42. PubMed ID: 20379106
    [Abstract] [Full Text] [Related]

  • 8. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K, Masuya M, Yamaguchi M, Isaka S, Nakase K, Kobayashi T, Nakamura S, Shiku H.
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [Abstract] [Full Text] [Related]

  • 9. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
    Delfau-Larue MH, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A, Salles G, Morschhauser F, Delarue R, Brice P, Bouabdallah R, Casasnovas O, Tilly H, Gaulard P, Haioun C.
    Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
    [Abstract] [Full Text] [Related]

  • 10. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
    Schetelig J, Fetscher S, Reichle A, Berdel WE, Beguin Y, Brunet S, Caballero D, Majolino I, Hagberg H, Johnsen HE, Kimby E, Montserrat E, Stewart D, Copplestone A, Rösler W, Pavel J, Kingreen D, Siegert W.
    Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
    [Abstract] [Full Text] [Related]

  • 11. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
    Imamura T, Yoshihara T, Morimoto A, Ishida H, Sugimoto T, Imashuku S.
    Pediatr Hematol Oncol; 2006 Nov; 23(1):19-24. PubMed ID: 16326408
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement.
    Hänel M, Fiedler F, Thorns C.
    Onkologie; 2001 Oct; 24(5):491-4. PubMed ID: 11694778
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
    Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R.
    Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
    [Abstract] [Full Text] [Related]

  • 14. T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation.
    Narumi H, Kojima K, Matsuo Y, Shikata H, Sekiya K, Niiya T, Bando S, Niiya H, Azuma T, Yakushijin Y, Sakai I, Yasukawa M, Fujita S.
    Bone Marrow Transplant; 2004 Jan; 33(1):99-101. PubMed ID: 14704662
    [Abstract] [Full Text] [Related]

  • 15. Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma.
    Hawley RC, Cankovic M, Zarbo RJ.
    Arch Pathol Lab Med; 2006 Nov; 130(11):1707-11. PubMed ID: 17076535
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S, Watanabe D, Miura K, Ozawa H, Tamada Y, Hara K, Matsumoto Y.
    Eur J Dermatol; 2007 Nov; 17(3):242-4. PubMed ID: 17478388
    [Abstract] [Full Text] [Related]

  • 17. Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.
    Némati F, Mathiot C, Grandjean I, Lantz O, Bordier V, Dewulf S, Ekue R, Di Santo JP, Poupon MF, Decaudin D.
    Anticancer Drugs; 2007 Oct; 18(9):1029-37. PubMed ID: 17704653
    [Abstract] [Full Text] [Related]

  • 18. Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
    Hess G, Flohr T, Huber C, Kolbe K, Derigs HG, Fischer T.
    Bone Marrow Transplant; 2003 May; 31(9):775-82. PubMed ID: 12732884
    [Abstract] [Full Text] [Related]

  • 19. [Angioimmunoblastic T-cell lymphoma complicated with EBV-associated B-cell lymphoma].
    Munemasa S, Sakai A, Sasaki N, Okikawa Y, Mihara K, Kimura A.
    Rinsho Ketsueki; 2005 Feb; 46(2):127-33. PubMed ID: 16447706
    [Abstract] [Full Text] [Related]

  • 20. [Use of Mabtera (rituximab) in treating patients with refractory courses of B-cell lymphoma, along with high-dose chemotherapy and autologous transplantation of hematopoietic stem cells].
    Ptushkin VV, Chimishkian KL, Zhukov NV, Osmanov DSh, Andreeva LIu, Tupitsyn NN, Larionova VB, Mkheidze DM, Poddubnaia NV.
    Ter Arkh; 2003 Feb; 75(1):65-8. PubMed ID: 12652962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.